The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling.

Oh, Jisun; Yoon, Hyo-Jin; Jang, Jeong-Hoon; Kim, Do-Hee; Surh, Young-Joon

Oh, Jisun; Yoon, Hyo-Jin; Jang, Jeong-Hoon; Kim, Do-Hee; Surh, Young-Joon.

Afiliação

Oh J; Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Yoon HJ; Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Jang JH; Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Kim DH; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea.
Surh YJ; Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.

J Ginseng Res ; 43(3): 421-430, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31308814